4.5 Review

Increasing O-GlcNAc levels: An overview of small-molecule inhibitors of O-GlcNAcase

期刊

BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
卷 1800, 期 2, 页码 107-121

出版社

ELSEVIER
DOI: 10.1016/j.bbagen.2009.07.028

关键词

O-GlcNAc; Nucleocytoplasmic glycosylation; Glycoprotein; O-GlcNAcase; OGA; Enzyme inhibitor; Glycoside hydrolase; Substrate-assisted catalysis

资金

  1. Natural Sciences and Engineering Research Council of Canada (NSERC)
  2. Canadian Institutes of Health Research (CIHR)
  3. Michael Smith Foundation of Health Research (MSFHR)

向作者/读者索取更多资源

The O-GlcNAc modification is found on many nucleocytoplasmic proteins.-he dynamic nature of O-GlcNAc, which in some ways is reminiscent of phosphorylation, has enabled investigators to modulate the stoichiometry of O-GlcNAc on proteins in order to study its function Although several genetic and pharmacological methods for manipulating O-GlcNAc levels have been described, one of the most direct approaches of increasing global O-GlcNAc levels is by using small-molecule inhibitors of O-GlcNAcase (OGA). As the interest in increasing O-GlcNAc levels has grown, so too has the number of OGA inhibitors. This review provides an overview of the available methods of increasing O-GlcNAc levels, with a special emphasis on inhibition of OGA by small molecules. Known inhibitors of OGA are discussed with particular attention on those most suitable for cell-based biological studies. Several examples in which OGA inhibitors have been used to study the functional role of the O-GlcNAc modification in biological systems are discussed, highlighting the pros and cons of different inhibitors. (C) 2008 Elsevier B.V. All rights reserved.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据